Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 2
Submit an article Journal homepage
17
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Idarubicin Containing Regimen in Multiple Myeloma: Preliminary Results of a Pilot Study Using a Modified "TANDEM" Transplant Program

G. Martinelli Department of Hematology-Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy
,
A. Agazzi Department of Hematology-Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy
,
D. Laszlo Department of Hematology-Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy
,
P. Santoro Department of Hematology-Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy
,
P. Mancuso Department of Hematology-Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy
,
G.C. Pruneri Department of Pathology, European Institute of Oncology, IRCCS, Milan, Italy
,
P. Greco Pharmacia CO, Milan, Italy
&
F. Bertolini Department of Hematology-Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy
 show all
Pages 299-302 | Published online: 01 Jul 2009

  • Vesole, D.H., Simic, A. and Lazarus, H.M. (2001) "Controversy in multiple myeloma transplants: tandem autotransplants and miniallogratt", Bone Marrow Transplant. 28, 725-735.
  • Attal, M., Harousseau, J.L., Stoppa, A.M., et al. (1996) "A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroup Francais du Myelome", New Engl. J. Med. 335. 2568-2576.
  • Vesole, D.H., Tricot, G., Jagannath, S., et at. (1996) "Autotransplant in multiple myeloma: what have we learned?", Blood 88(3), 838-847.
  • Barlogie, B., Jagannath, S., Vesole, D.H., et al. (1997) "Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma", Blood 89, 789-793.
  • Gahrton, G., Svensson, H., Cavo, M., et al. (2001) "Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres", Br. J. Haematol. 113(1), 209-216.
  • Alegre, A., Lamana, M., Arranz, R., et al. (1995) "Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma", Br. J. Haematol. 91, 380-386.
  • Schiller, G., Nimer, S., Vescio, R., et al. (1994) "Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma", Bone Marrow Transplant. 14, 131-136.
  • Long, G.D., Chao, N.J., Hu. WW., et al. (1996) "High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma". Cancer 78(12), 2502-2509.
  • Dimopoulos, M.A., Alexanian, R., Przepiorka, et al. (1993) "Thiotepa, busulfan and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high risk multiple myeloma", Blood 82, 2324-2328.
  • Ballester, O.F., Moscinski, L.C., Fields, K.K., et al. (1997) "Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel induction chemotherapy regimen for patients with high-risk multiple myeloma". Br. J. Haematol. 96, 746-748.
  • Wiernik, P.H. (1992) "Cytarabin plus idarubicin or daunorubicin as induction and consolidation therapy for previous untreated adult patients with acute myeloid leukemia". Blood 79, 313-319
  • Fields, S.M and Koeller, J.M. (1991) "ldarubicin: a second generation antracyclin, DICP". Ann. Pharmacother. 25, 505-517.
  • Heyll, A., Sohngen, D., Kobbe, G., et al. (1997) "Idarubicin melphalan and cyclophosphamide: an intensified high dose regimen for the treatment of myeloma patients", Leukemia 11, 32-34.
  • Meloni, G., Capria, S., Trasarti, S., et al. (2000) "High-dose idarubicin. busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study". Bone Marrow Transplant. 26, 1045-1049.
  • Corsini, C., Ghielmini. M., Mancuso, P., et al. (2000) "ldarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin". Br. J. Cancer 82, 524-528.
  • Martinelli, G., Pastano, R., Alietti, A., et al. (2000) "High dose chemotherapy with idarubicin and melphalan and peripheral blood stem cell transplantation in patients with poor risk or relapsed high grade non Hodgkin lymphoma". Haeinatologica 86(Suppl. 10), 1-279. Abst P0128.
  • Durie, B.G. and Salmon, S. (1975) "A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival". Cancer 36, 842-854.
  • Gore, M.E., Selby, P.J., Clark, P.I., et al. (1989) "Intensive treatment of multiple myeloma and criteria for complete response", Lancet 2, 879-882.
  • World Health Organization (1979) WHO Handbock for Reporting Results of Cancer Treatment (World Health Organization. Geneva). p. 38.
  • Mandelli, F., Petti, M.C., Ardia, A., et al. (1991) "A Randomized clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non lymphoid leukemia". Eur. J. Cancer 27, 750-755.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.